Breaking News Instant updates and real-time market news.

2020-11-25 01:45:07 01:45 11/25/20 11/25 01:45 11/25/20 01:45	U.S. personal income/consumption preview U.S. personal income/consumption preview: income should edge up 0.1% in October after a 0.9% increase in September, alongside a 0.6% climb in consumption after a 1.4% bounce in September. April income faced a big boost from the CARES Act that has been partly unwound in each month since, alongside declining jobless benefits. Analysts expect a savings rate pull-back to 13.5% from 14.0% in September, further unwinding from the 33.7% peak in April. Our Q4 income forecast assumes no further stimulus spending this year. Analysts expect a 9.0% growth pace for real consumption in Q4, after a 40.7% surge in Q3. And analysts peg disposable income growth at -2.2% in Q4, after a -13.2% Q3 rate.

2020-11-25 01:45:07

01:45

11/25/20

11/25

01:45

11/25/20

01:45

U.S. personal income/consumption preview

U.S. personal income/consumption preview: income should edge up 0.1% in October after a 0.9% increase in September, alongside a 0.6% climb in consumption after a 1.4% bounce in September. April income faced a big boost from the CARES Act that has been partly unwound in each month since, alongside declining jobless benefits. Analysts expect a savings rate pull-back to 13.5% from 14.0% in September, further unwinding from the 33.7% peak in April. Our Q4 income forecast assumes no further stimulus spending this year. Analysts expect a 9.0% growth pace for real consumption in Q4, after a 40.7% surge in Q3. And analysts peg disposable income growth at -2.2% in Q4, after a -13.2% Q3 rate.

TODAY'S FREE FLY STORIES

Options	JinkoSolar call volume above normal and directionally bullish » 15:45 01/19/21 01/19 15:45 01/19/21 15:45 JKS JinkoSolar $63.18 / +5.18 (+8.93%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options JKS JinkoSolar $63.18 / +5.18 (+8.93%) 12/30/20 Chairman Xiande Li lowers stake in JinkoSolar to 9.1% from 11.8% 12/29/20 JinkoSolar modules in Australia generate almost 550 MW AC 12/18/20 JinkoSolar rises 15.2% 12/15/20 JinkoSolar rises 11.8% JKS JinkoSolar $63.18 / +5.18 (+8.93%) 01/04/21 Goldman Sachs JinkoSolar price target raised to $39 from $34 at Goldman Sachs 12/30/20 GLJ Research GLJ Research keeps Sell on JinkoSolar after chairman, CEO dump shares 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital 12/15/20 Roth Capital Solar tax credit extension would be positive surprise, says Roth Capital JKS JinkoSolar $63.18 / +5.18 (+8.93%) 12/07/20 JinkoSolar sees Q4 revenue $1.31B-$1.43B. consensus $1.52B 12/07/20 JinkoSolar reports Q3 EPS $1.06, consensus 85c 09/23/20 JinkoSolar sees Q3 revenue $1.22B-$1.3B, consensus $1.22B 09/23/20 JinkoSolar reports Q2 EPS $1.20, consensus 61c JKS JinkoSolar $63.18 / +5.18 (+8.93%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says JKS JinkoSolar $63.18 / +5.18 (+8.93%) 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev JKS JinkoSolar $63.18 / +5.18 (+8.93%) 12/22/20 JinkoSolar call volume above normal and directionally bullish 12/22/20 Unusually active option classes on open December 22nd 12/18/20 JinkoSolar call volume above normal and directionally bullish 12/18/20 Unusually active option classes on open December 18th
Options	Interactive Brokers options imply 2.7% move in share price post-earnings » 15:34 01/19/21 01/19 15:34 01/19/21 15:34 IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) 01/04/21 Interactive Brokers reports December DARTs up 198% from prior year 12/23/20 Interactive Brokers establishes office in Ireland 12/04/20 Interactive Brokers to acquire retail brokerage segment from Folio Investments 12/01/20 Interactive Brokers reports November DARTs up 179% y/y IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) 01/05/21 Compass Point Interactive Brokers price target raised to $65 from $62 at Compass Point 01/04/21 Goldman Sachs Interactive Brokers growth still firing on all cylinders, says Goldman Sachs 12/02/20 Fly Intel: Top five analyst upgrades 12/02/20 Compass Point Interactive Brokers upgraded to Buy with $62 price target at Compass Point IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) 10/20/20 Interactive Brokers reports Q3 adjusted EPS 53c, consensus 55c 07/21/20 Interactive Brokers reports Q2 adjusted EPS 57c, consensus 31c IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) 11/17/20 Trading platform Robinhood may go public next year, Bloomberg reports 10/15/20 Robinhood says almost 2,000 brokerage accounts hacked, Bloomberg reports IBKR Interactive Brokers $69.76 / +0.69 (+1.00%) 10/20/20 Fly Intel: After-Hours Movers 02/24/21 22nd Annual Virtual Financial Services Forum 16:30 Today Interactive Brokers - IBKR
Hot Stocks	Carnival CEO sells over 62,000 common shares » 15:33 01/19/21 01/19 15:33 01/19/21 15:33 CCL Carnival $20.95 / +0.155 (+0.75%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CCL Carnival $20.95 / +0.155 (+0.75%) 15:32 Today Carnival CFO sells over 49,000 common shares 01/11/21 Carnival: Unable to predict when entire fleet will return to normal operations 01/11/21 Carnival: Cumulative advanced bookings for 2H21 within historical range 01/11/21 Carnival reports preliminary Q4 adjusted net loss ($1.9B) CCL Carnival $20.95 / +0.155 (+0.75%) 01/12/21 Deutsche Bank Carnival price target raised to $16 from $13 at Deutsche Bank 10/30/20 Stifel CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel 10/16/20 Deutsche Bank Deutsche sees Covid newsflow remaining drag on cruise stocks 10/07/20 JPMorgan Royal Caribbean price target raised to $79 from $67 at JPMorgan CCL Carnival $20.95 / +0.155 (+0.75%) 07/21/20 Carnival reinitiates installation program of BioHiTech food waste digesters 02 Apr CCL Carnival $20.95 / +0.155 (+0.75%) 01/11/21 Carnival tells WSJ Q4 sales in tens of millions, consensus $156M 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says 09/30/20 CDC Director Redfield overruled on cruise ship 'no-sail order,' Axios reports CCL Carnival $20.95 / +0.155 (+0.75%) 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday CCL Carnival $20.95 / +0.155 (+0.75%) 01/14/21 Carnival call volume above normal and directionally bullish 12/23/20 Early notable gainers among liquid option names on December 23rd 11/24/20 Early notable gainers among liquid option names on November 24th 11/16/20 Early notable gainers among liquid option names on November 16th
Hot Stocks	Carnival CFO sells over 49,000 common shares » 15:32 01/19/21 01/19 15:32 01/19/21 15:32 CCL Carnival $20.96 / +0.165 (+0.79%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CCL Carnival $20.96 / +0.165 (+0.79%) 01/11/21 Carnival: Unable to predict when entire fleet will return to normal operations 01/11/21 Carnival: Cumulative advanced bookings for 2H21 within historical range 01/11/21 Carnival reports preliminary Q4 adjusted net loss ($1.9B) 01/08/21 Carnival's AIDA extends pause of cruise season until end of February CCL Carnival $20.96 / +0.165 (+0.79%) 01/12/21 Deutsche Bank Carnival price target raised to $16 from $13 at Deutsche Bank 10/30/20 Stifel CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel 10/16/20 Deutsche Bank Deutsche sees Covid newsflow remaining drag on cruise stocks 10/07/20 JPMorgan Royal Caribbean price target raised to $79 from $67 at JPMorgan CCL Carnival $20.96 / +0.165 (+0.79%) 07/21/20 Carnival reinitiates installation program of BioHiTech food waste digesters 02 Apr CCL Carnival $20.96 / +0.165 (+0.79%) 01/11/21 Carnival tells WSJ Q4 sales in tens of millions, consensus $156M 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says 09/30/20 CDC Director Redfield overruled on cruise ship 'no-sail order,' Axios reports CCL Carnival $20.96 / +0.165 (+0.79%) 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday CCL Carnival $20.96 / +0.165 (+0.79%) 01/14/21 Carnival call volume above normal and directionally bullish 12/23/20 Early notable gainers among liquid option names on December 23rd 11/24/20 Early notable gainers among liquid option names on November 24th 11/16/20 Early notable gainers among liquid option names on November 16th
Recommendations	NN Group price target lowered to EUR 40 from EUR 41 at Barclays » 15:29 01/19/21 01/19 15:29 01/19/21 15:29 NNGRY NN Group $0.00 / + (+0.00%) Barclays analyst Claudia… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NNGRY NN Group $0.00 / + (+0.00%) 14:54 Today Morgan Stanley NN Group price target raised to EUR 40.40 from EUR 36.90 at Morgan Stanley 01/06/21 Deutsche Bank NN Group downgraded to Hold from Buy at Deutsche Bank 11/24/20 Barclays NN Group price target raised to EUR 41 from EUR 40 at Barclays 11/12/20 Morgan Stanley NN Group price target raised to EUR 36.90 from EUR 35.60 at Morgan Stanley

On The Fly	Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades » 15:26 01/19/21 01/19 15:26 01/19/21 15:26 ADPT Adaptive Biotechnologies $67.13 / +2.2 (+3.39%) , REVG REV Group $10.64 / +1.52 (+16.67%) , CCEL Cryo-Cell $0.00 / + (+0.00%) , SPLP Steel Partners $13.78 / +0.43 (+3.22%) , RILY B. Riley Financial $48.82 / -0.84 (-1.69%) , FB Facebook $261.66 / +10.13 (+4.03%) , NBIX Neurocrine $108.28 / +0.37 (+0.34%) , ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) Welcome to "Fly… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ADPT REVG SPLP RILY FB NBIX ONEM ADPT Adaptive Biotechnologies $67.13 / +2.2 (+3.39%) 01/11/21 Adaptive in pact with AstraZeneca to investigate use of immunoSEQ T-MAP 12/06/20 Adaptive announces new data demonstrating impact of clonoSEQ Assay 11/13/20 Adaptive Biotechnologies announces preliminary data on T-Detect Assay 08/06/20 Adaptive Biotechnologies receives expanded FDA clearance for clonoSEQ Assay REVG REV Group $10.64 / +1.52 (+16.67%) 01/15/21 REV Group CFO buys 15K shares of common stock 01/07/21 REV Group falls -10.0% 09/09/20 REV Group rises 7.8% 08/20/20 Kaman CEO Neal Keating to retire, Ian Walsh to succeed SPLP Steel Partners $13.78 / +0.43 (+3.22%) 01/15/21 Steel Partners rises 16.2% 01/15/21 Steel Partners rises 15.7% 01/14/21 Steel Partners director buys 77.3K shares of common stock 12/30/20 Steel Partners rises 21.3% RILY B. Riley Financial $48.82 / -0.84 (-1.69%) 01/11/21 B. Riley Financial to acquire remaining shares of National Holdings for $3.25 01/11/21 B. Riley Financial to acquire remaining shares of National Holdings for $3.25 12/17/20 B. Riley Financial announces strategic investment in Lingo Communications 12/02/20 B. Riley Financial acquires interest in Justice brand assets FB Facebook $261.66 / +10.13 (+4.03%) 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification 01/11/21 Facebook names Roy Austin as VP of Civil RIghts, deputy general counsel 01/10/21 Fly Intel: Top five weekend stock stories NBIX Neurocrine $108.28 / +0.37 (+0.34%) 01/08/21 Neurocrine plans to initiate seven mid-to-late stage clinical studies in 2021 12/22/20 Voyager says clinical hold placed on RESTOR-1 clinical trial of NBIb-1817 11/09/20 Neurocrine falls 13% to $89.55 after reporting mixed Q3 results 11/09/20 Neurocrine sees FY20 combined GAAP R&D and SG&A expenses $880M-$900M ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) 01/12/21 One Medical extends public COVID-19 vaccination effors 12/30/20 1Life Healthcare begins COVID-19 vaccination in San Francisco 09/30/20 One Medical, Houston Methodist to partner on coordinated care in Houston 09/09/20 One Medical, Ohio State Wexner Medical Center announce partnership ADPT REVG CCEL SPLP RILY FB NBIX ONEM ADPT Adaptive Biotechnologies $67.13 / +2.2 (+3.39%) 06:48 Today BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 12/17/20 BTIG BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks' 11/12/20 BTIG Adaptive Biotechnologies price target raised to $63 from $60 at BTIG 11/11/20 JPMorgan Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan REVG REV Group $10.64 / +1.52 (+16.67%) 01/08/21 Baird REV Group result pretty much as expected, says Baird 12/17/20 Baird REV Q4 results delay could portend impending portfolio realignment, says Baird 12/15/20 Morgan Stanley REV Group upgraded to Equal Weight on improved RV outlook at Morgan Stanley 12/15/20 Morgan Stanley REV Group upgraded to Equal Weight from Underweight at Morgan Stanley CCEL Cryo-Cell $0.00 / + (+0.00%) SPLP Steel Partners $13.78 / +0.43 (+3.22%) RILY B. Riley Financial $48.82 / -0.84 (-1.69%) FB Facebook $261.66 / +10.13 (+4.03%) 10:13 Today JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 09:52 Today Fly Intel: Top five analyst upgrades 07:28 Today KeyBanc Facebook price target raised to $345 from $340 at KeyBanc 05:02 Today BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital NBIX Neurocrine $108.28 / +0.37 (+0.34%) 12/29/20 Cantor Fitzgerald Neurocrine price target lowered to $121 from $168 at Cantor Fitzgerald 12/07/20 Wedbush Neurocrine price target lowered to $121 from $129 at Wedbush 11/12/20 Canaccord Neurocrine price target lowered to $122 from $145 at Canaccord 11/10/20 SVB Leerink Neurocrine price target lowered to $100 from $120 at SVB Leerink ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) 10:07 Today JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/08/21 Piper Sandler 1Life Healthcare price target raised to $51 from $44 at Piper Sandler 01/07/21 Canaccord 1Life Healthcare price target raised to $50 from $46 at Canaccord 01/06/21 BTIG 1Life Healthcare initiated with a Neutral at BTIG ADPT REVG SPLP RILY FB NBIX ONEM ADPT Adaptive Biotechnologies $67.13 / +2.2 (+3.39%) 11/10/20 Adaptive Biotechnologies reports Q3 EPS (27c), consensus (28c) 08/10/20 Adaptive Biotechnologies reports Q2 EPS (26c), consensus (28c) REVG REV Group $10.64 / +1.52 (+16.67%) 01/07/21 REV Group reports Q4 adjusted EPS 19c, consensus 16c 12/17/20 REV Group reports preliminary Q4 revenue $616M, consensus $614.14M 09/09/20 REV Group reports Q3 adj. EPS 10c, consensus 0c SPLP Steel Partners $13.78 / +0.43 (+3.22%) 11/03/20 Steel Partners reports Q3 adj. EBITDA $73.3M vs. $59.2M last year RILY B. Riley Financial $48.82 / -0.84 (-1.69%) 01/12/21 B. Riley Financial sees FY20 EPS $7.20-$7.39 01/12/21 B. Riley Financial raises Q4 EPS view to $6.18-$6.38 from $4.15-$4.27 FB Facebook $261.66 / +10.13 (+4.03%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 NBIX Neurocrine $108.28 / +0.37 (+0.34%) 01/08/21 Neurocrine sees Q4 INGREZZA net product sales approximately $240M 11/09/20 Neurocrine reports Q3 non-GAAP EPS 97c, consensus 22c 08/03/20 Neurocrine reports Q2 non-GAAP EPS $1.42, consensus 73c ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) 11/10/20 1Life Healthcare sees FY20 revenue $362M-$367M, consensus $333.88M 11/10/20 1Life Healthcare sees Q4 revenue $104M-$109M, consensus $90.9M 11/10/20 1Life Healthcare reports Q3 EPS (13c), consensus (19c) 08/12/20 One Medical sees Q3 revenue $84M-$89M, consensus $74.6M 13 Jan 23 Nov 16 Jul 25 Jun 31 Jan 24 Jan FB FB Facebook $261.66 / +10.13 (+4.03%) 15:21 Today India requests that WhatsApp pull privacy policy update, Reuters says 11:03 Today Instagram's Mosseri says removing Trump was the right decision, Verge says 06:08 Today WhatsApp delaying privacy policy by three months, The Verge reports 01/17/21 Facebook to ban ads promoting weapon accessories, protective gear, Reuters says ADPT REVG RILY FB NBIX ONEM ADPT Adaptive Biotechnologies $67.13 / +2.2 (+3.39%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades REVG REV Group $10.64 / +1.52 (+16.67%) 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades RILY B. Riley Financial $48.82 / -0.84 (-1.69%) 11/09/20 Fly Insider: Xerox, At Home Group among week's notable insider trades FB Facebook $261.66 / +10.13 (+4.03%) 10:05 Today Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday NBIX Neurocrine $108.28 / +0.37 (+0.34%) 11/09/20 Fly Intel: After-Hours Movers 08/03/20 Fly Intel: After-Hours Movers ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) 12/16/20 Teladoc slides on report of Amazon building telehealth business 11/10/20 Fly Intel: After-Hours Movers 08/12/20 Fly Intel: After-Hours Movers 01/20/21 Aesthetics Tech Virtual Summit 2021 01/27/21 Facebook - FB FB ONEM FB Facebook $261.66 / +10.13 (+4.03%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish ONEM 1Life Healthcare $47.03 / +4.385 (+10.28%) 09/24/20 Unusually active option classes on open September 24th
Recommendations	Icade price target lowered to EUR 67 from EUR 68 at Barclays » 15:25 01/19/21 01/19 15:25 01/19/21 15:25 CDMGF Icade $0.00 / + (+0.00%) Barclays analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CDMGF Icade $0.00 / + (+0.00%) 11/09/20 Goldman Sachs Icade upgraded to Neutral from Sell at Goldman Sachs 10/23/20 Deutsche Bank Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank 10/20/20 BofA Icade upgraded to Buy from Neutral at BofA 09/03/20 Morgan Stanley Icade price target lowered to EUR 60 from EUR 75 at Morgan Stanley
On The Fly	Lumentum slides after announcing $5.7B merger deal with Coherent » 15:22 01/19/21 01/19 15:22 01/19/21 15:22 LITE Lumentum $95.61 / -10.58 (-9.96%) , COHR Coherent $199.54 / +47.62 (+31.35%) , AAPL Apple $128.05 / +0.98 (+0.77%) Shares of Lumentum (LITE)… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LITE COHR AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 06:35 Today Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion 11/16/20 Lumentum acquires TriLumina assets; terms not disclosed 09/04/20 FCC says U.S. rural telecom networks need $1.84B to remove Huawei, ZTE equipment 08/11/20 Lumentum CEO says 'better than projected results' in Q4 COHR Coherent $199.54 / +47.62 (+31.35%) 06:35 Today Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion 12/16/20 Coherent, II-VI enter supply agreement 12/16/20 II-VI, Coherent enter supply agreement for automotive laser welding solutions 11/10/20 Coherent CEO says 'cautiously optimistic on 5G upgrade cycle AAPL Apple $128.05 / +0.98 (+0.77%) 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 VirnetX says court affirms jury award of $502.8M against Apple 01/15/21 VirnetX jumps after court denies Apple motion for new patent trial 01/14/21 Abbott launches NeuroSphere myPath digital health app LITE COHR AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 14:54 Today Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/12/21 MKM Partners Lumentum price target raised to $138 from $120 at MKM Partners 01/12/21 Susquehanna Susquehanna names top five M&A candidates in Semi space 01/11/21 B. Riley Securities Lumentum price target raised to $123 from $101 at B. Riley Securities COHR Coherent $199.54 / +47.62 (+31.35%) 14:54 Today Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 01/12/21 Barclays Coherent downgraded to Underweight from Equal Weight at Barclays 11/12/20 Longbow Coherent downgraded to Neutral ahead of transition year at Longbow 11/12/20 Longbow Coherent downgraded to Neutral from Buy at Longbow AAPL Apple $128.05 / +0.98 (+0.77%) 14:54 Today Craig-Hallum Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum 05:02 Today BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital 01/15/21 Goldman Sachs Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating 01/15/21 Loop Capital Apple price target raised to $155 from $131 at Loop Capital LITE COHR AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 06:38 Today Lumentum reports preliminary Q2 EPS $1.91-$1.99, consensus $1.82 11/02/20 Lumentum sees Q2 non-GAAP EPS $1.70-$1.90, consensus $1.60 11/02/20 Lumentum reports Q1 non-GAAP EPS $1.78, consensus $1.47 08/11/20 Lumentum sees Q1 adjusted EPS $1.40-$1.55, consensus $1.33 COHR Coherent $199.54 / +47.62 (+31.35%) 06:40 Today Coherent reports preliminary Q1 revenue $325M-$327M, consensus $313.09M 11/10/20 Coherent sees Q1 revenue $300M-$320M, consensus $341.28M 11/10/20 Coherent reports Q4 adjusted EPS $1.01, consensus 80c 08/04/20 Coherent sees Q4 revenue $290M-$320M, consensus $325.49M AAPL Apple $128.05 / +0.98 (+0.77%) 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 10/29/20 Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year 10/29/20 Apple reports Q4 EPS 73c, consensus 70c LITE COHR AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 09:57 Today NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says COHR Coherent $199.54 / +47.62 (+31.35%) 09:57 Today NeoPhotonics speculated as potential takeover target at Dealreporter 01/18/21 Lumentum in advanced talks to acquire Coherent, WSJ reports AAPL Apple $128.05 / +0.98 (+0.77%) 01/17/21 Apple considering foldable iPhone, minor changes for 2021 models, Bloomberg says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/15/21 Apple to re-close stores in Texas, North Carolina, Georgia, Bloomberg says 01/15/21 Apple to challenge Spotify with podcast subscription service, Information says LITE COHR AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 12:16 Today Fly Intel: Wall Street's top stories at midday 09:17 Today Fly Intel: Pre-market Movers 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 11/02/20 Fly Intel: Pre-market Movers COHR Coherent $199.54 / +47.62 (+31.35%) 12:16 Today Fly Intel: Wall Street's top stories at midday 09:17 Today Fly Intel: Pre-market Movers AAPL Apple $128.05 / +0.98 (+0.77%) 10:05 Today Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 02/11/21 Technology & Internet Virtual Conference 08:30 Today Coherent - COHR 08:30 Today Lumentum - LITE 01/27/21 Apple - AAPL 02/02/21 Lumentum - LITE 02/23/21 Apple, Inc. LITE AAPL LITE Lumentum $95.61 / -10.58 (-9.96%) 01/05/21 Lumentum call volume above normal and directionally bullish 08/17/20 Lumentum put volume heavy and directionally bearish 08/03/20 Lumentum call volume above normal and directionally bullish AAPL Apple $128.05 / +0.98 (+0.77%) 08:55 Today Notable open interest changes for January 19th 01/15/21 Notable open interest changes for January 15th 01/14/21 Notable open interest changes for January 14th 01/13/21 Notable open interest changes for January 13th
Recommendations	Galapagos price target raised to $125 from $85.50 at Barclays » 15:21 01/19/21 01/19 15:21 01/19/21 15:21 GLPG Galapagos $107.48 / +7.48 (+7.48%) Barclays analyst Emily… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly GLPG Galapagos $107.48 / +7.48 (+7.48%) 12/15/20 Galapagos to assume development, manufacturing, other rights for Jyseleca 12/15/20 Gilead will not pursue FDA approval of Jyseleca for RA 12/01/20 Galapagos announces 1st dosing in Mangrove trial in GLPG2737 with ADPKD patient 11/30/20 Galapagos presents results with GLPG1205 in IPF patients in Pinta trial GLPG Galapagos $107.48 / +7.48 (+7.48%) 05:55 Today Morgan Stanley Galapagos upgraded to Overweight from Equal Weight at Morgan Stanley 12/18/20 Truist Gilead price target lowered to $62 from $67 at Truist 12/17/20 Maxim Galapagos price target lowered to $140 from $170 at Maxim 12/17/20 Oppenheimer Gilead price target lowered to $100 from $105 at Oppenheimer GLPG Galapagos $107.48 / +7.48 (+7.48%) 08/06/20 Galapagos reports first half EPS EUR (2.55) vs. (1.76) last year GLPG Galapagos $107.48 / +7.48 (+7.48%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/15/20 Fly Intel: After-Hours Movers 08/19/20 Fly Intel: Wall Street's top stories for Wednesday
Periodicals	India requests that WhatsApp pull privacy policy update, Reuters says » 15:21 01/19/21 01/19 15:21 01/19/21 15:21 FB Facebook $261.44 / +9.91 (+3.94%) India's Ministry of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB Facebook $261.44 / +9.91 (+3.94%) 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification 01/11/21 Facebook names Roy Austin as VP of Civil RIghts, deputy general counsel 01/10/21 Fly Intel: Top five weekend stock stories FB Facebook $261.44 / +9.91 (+3.94%) 10:13 Today JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 09:52 Today Fly Intel: Top five analyst upgrades 07:28 Today KeyBanc Facebook price target raised to $345 from $340 at KeyBanc 05:02 Today BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital FB Facebook $261.44 / +9.91 (+3.94%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 FB Facebook $261.44 / +9.91 (+3.94%) 11:03 Today Instagram's Mosseri says removing Trump was the right decision, Verge says 06:08 Today WhatsApp delaying privacy policy by three months, The Verge reports 01/17/21 Facebook to ban ads promoting weapon accessories, protective gear, Reuters says 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says FB Facebook $261.44 / +9.91 (+3.94%) 10:05 Today Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/20/21 Aesthetics Tech Virtual Summit 2021 01/27/21 Facebook - FB FB Facebook $261.44 / +9.91 (+3.94%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish

Options	Call seller writes $35M notional block at six month term » 15:20 01/19/21 01/19 15:20 01/19/21 15:20 SLV iShares Silver Trust $23.34 / +0.39 (+1.70%) Call seller writes $35M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options Technical Analysis SLV iShares Silver Trust $23.34 / +0.39 (+1.70%) 12/28/20 Unusually active option classes on open December 28th 12/17/20 Unusually active option classes on open December 17th 11/05/20 Unusually active option classes on open November 5th 08/10/20 Silver ETF option volume on track for 1.3M contracts SLV iShares Silver Trust $23.34 / +0.39 (+1.70%) 07/24/20 On The Fly: ETF fund flow highlights
Options	J B Hunt Transport Services options imply 5.8% move in share price post-earnings » 15:19 01/19/21 01/19 15:19 01/19/21 15:19 JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) 12/22/20 J.B. Hunt, University of Arkansas announce $2.25M collaboration on diversity 11/30/20 J.B. Hunt subsidiary acquires Mass Movement 11/24/20 J.B. Hunt makes leadership moves, names John Kuhlow as CFO 10/16/20 J.B. Hunt reports Q3 operating income $175.5M, up 5% JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) 06:10 Today Credit Suisse J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse 01/06/21 Citi J.B. Hunt upgraded to Buy from Neutral at Citi 01/05/21 Stephens J.B. Hunt price target raised to $167 from $155 at Stephens 11/30/20 Deutsche Bank J.B. Hunt price target raised to $139 from $132 at Deutsche Bank JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) 13:40 Today Notable companies reporting after market close 10/16/20 J.B. Hunt reports Q3 EPS $1.18, consensus $1.27 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) 10/16/20 Fly Intel: Pre-market Movers 07/27/20 Fly Insider: CASI Pharma, Datadog among weeks notable insider trades 17:00 Today J.B. Hunt - JBHT JBHT J.B. Hunt $148.78 / -2.87 (-1.89%) 10/01/20 Early notable gainers among liquid option names on October 1st
Hot Stocks	Surgical Directions announces management buyout deal with Mednax » 15:19 01/19/21 01/19 15:19 01/19/21 15:19 MD Mednax $23.98 / +0.39 (+1.65%) Surgical Directions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MD Mednax $23.98 / +0.39 (+1.65%) 12/16/20 Mednax completes sale of Mednax Radiology Solutions to Radiology Partners 11/13/20 Halozyme to replace Mednax in S&P 400 at open on 11/13 11/13/20 Mednax to replace Washington Prime in S&P 600 at open on 11/13 11/05/20 Mednax to replace Washington Prime in S&P 600 at open on 11/13 MD Mednax $23.98 / +0.39 (+1.65%) 01/05/21 Truist Mednax price target raised to $26 from $20 at Truist 10/19/20 Fly Intel: Top five analyst downgrades 10/19/20 Deutsche Bank Mednax downgraded to Sell from Hold at Deutsche Bank 06/09/20 Mizuho Mednax price target raised to $20 from $17 at Mizuho MD Mednax $23.98 / +0.39 (+1.65%) 11/06/20 Mednax reports Q3 adjusted EPS 37c, consensus 40c 07/30/20 Mednax reports Q2 adjusted EPS 32c, consensus 9c MD Mednax $23.98 / +0.39 (+1.65%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers
Recommendations	ConvaTec price target raised to 250 GBp from 245 GBp at Barclays » 15:18 01/19/21 01/19 15:18 01/19/21 15:18 CNVVY ConvaTec $0.00 / + (+0.00%) Barclays analyst Hassan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CNVVY ConvaTec $0.00 / + (+0.00%) 01/04/21 JPMorgan ConvaTec upgraded to Neutral from Underweight at JPMorgan 12/09/20 Morgan Stanley ConvaTec price target lowered to 208 GBp from 210 GBp at Morgan Stanley 11/18/20 Morgan Stanley ConvaTec price target raised to 210 GBp from 200 GBp at Morgan Stanley 10/29/20 JPMorgan ConvaTec price target raised to 176 GBp from 175 GBp at JPMorgan
Recommendations	Coca-Cola Femsa price target raised to $50 from $45 at Barclays » 15:17 01/19/21 01/19 15:17 01/19/21 15:17 KOF Coca-Cola Femsa $46.80 / -0.81 (-1.70%) Barclays analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KOF Coca-Cola Femsa $46.80 / -0.81 (-1.70%) 07/13/20 Barclays Coca-Cola Femsa downgraded on South American exposure at Barclays 07/13/20 Barclays Coca-Cola Femsa downgraded to Equal Weight from Overweight at Barclays 06/09/20 Itau BBA Coca-Cola Femsa upgraded to Outperform from Market Perform at Itau BBA 04/24/20 Scotiabank Coca-Cola Femsa downgraded to Sector Perform from Outperform at Scotiabank

Technical Analysis	NASDAQ market internals summary » 15:17 01/19/21 01/19 15:17 01/19/21 15:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 15:16 01/19/21 01/19 15:16 01/19/21 15:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary
Recommendations	CaixaBank price target raised to EUR 2.60 from EUR 2.50 at Barclays » 15:15 01/19/21 01/19 15:15 01/19/21 15:15 CAIXY CaixaBank $0.00 / + (+0.00%) Barclays analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CAIXY CaixaBank $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares CAIXY CaixaBank $0.00 / + (+0.00%) 06:59 Today Societe Generale CaixaBank upgraded to Buy from Hold at Societe Generale 01/11/21 Deutsche Bank CaixaBank price target raised to EUR 2.75 from EUR 2.70 at Deutsche Bank 12/14/20 JPMorgan CaixaBank price target raised to EUR 2.35 from EUR 2.20 at JPMorgan 11/25/20 HSBC CaixaBank downgraded to Hold from Buy at HSBC CAIXY CaixaBank $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports 09/03/20 Bankia, Caixabank say they are considering merger, Bloomberg says
Conference/Events	New Fortress Energy to hold an investor update conference call » 15:11 01/19/21 01/19 15:11 01/19/21 15:11 NFE New Fortress Energy $49.81 / +0.98 (+2.01%) Management provides an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options NFE New Fortress Energy $49.81 / +0.98 (+2.01%) 01/13/21 Golar LNG Partners to be acquired by New Fortress Energy for $3.55 per unit 01/13/21 Golar LNG, Stonepeak to sell 100% of Hygo Energy Transtion to New Fortress 01/13/21 New Fortress Energy to buy Hygo ,Golar LNG Partners combined in $5B deal 12/21/20 New Fortress Energy signs two long-term LNG agreements NFE New Fortress Energy $49.81 / +0.98 (+2.01%) 01/15/21 Evercore ISI New Fortress Energy price target raised to $67 from $53 at Evercore ISI 01/14/21 JMP Securities New Fortress Energy price target raised to $69 from $45 at JMP Securities 01/14/21 Stifel Golar LNG Partners downgraded to Hold from Buy at Stifel 11/18/20 BTIG New Fortress Energy price target raised to $45 from $30 at BTIG NFE New Fortress Energy $49.81 / +0.98 (+2.01%) 10/29/20 New Fortress Energy reports Q3 EPS (21c), consensus 12c 08/03/20 New Fortress Energy reports Q2 EPS (32c), consensus (30c) 16 Dec NFE New Fortress Energy $49.81 / +0.98 (+2.01%) 01/13/21 Fly Intel: Pre-market Movers NFE New Fortress Energy $49.81 / +0.98 (+2.01%) 07/20/20 Seven new option listings and eight option delistings on July 20th
Recommendations	Bankinter price target raised to EUR 4.10 from EUR 3.60 at Barclays » 15:11 01/19/21 01/19 15:11 01/19/21 15:11 BKNIY Bankinter $0.00 / + (+0.00%) Barclays analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BKNIY Bankinter $0.00 / + (+0.00%) 01/15/21 Morgan Stanley Bankinter price target raised to EUR 4.70 from EUR 4.15 at Morgan Stanley 11/05/20 JPMorgan Bankinter price target lowered to EUR 3.30 from EUR 3.50 at JPMorgan 10/27/20 Santander Bankinter upgraded to Buy from Hold at Santander 10/09/20 Barclays Bankinter price target lowered to EUR 3.80 from EUR 4.20 at Barclays

Recommendations	Banco Santander price target raised to EUR 3.10 from EUR 2.90 at Barclays » 15:09 01/19/21 01/19 15:09 01/19/21 15:09 SAN Banco Santander $3.27 / -0.02 (-0.61%) Barclays analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SAN Banco Santander $3.27 / -0.02 (-0.61%) 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 11/16/20 Santander agrees to acquire technology assets from Wirecard 07/31/20 SHUSA's request approved for certain exceptions to FRB interim policy SAN Banco Santander $3.27 / -0.02 (-0.61%) 01/15/21 Morgan Stanley Banco Santander price target raised to EUR 3.50 from EUR 3.30 at Morgan Stanley 01/11/21 Deutsche Bank Banco Santander price target raised to EUR 2.85 from EUR 2.80 at Deutsche Bank 01/11/21 UBS Banco Santander upgraded to Buy from Neutral at UBS 12/14/20 JPMorgan Banco Santander price target raised to EUR 2.50 from EUR 2.30 at JPMorgan SAN Banco Santander $3.27 / -0.02 (-0.61%) 10/30/20 Santander Chile reports Q3 EPS 28c, consensus 26c SAN Banco Santander $3.27 / -0.02 (-0.61%) 11/13/20 Santander plans to cut 4,000 positions, Reuters reports SAN Banco Santander $3.27 / -0.02 (-0.61%) 11/16/20 Fly Intel: Wall Street's top stories for Monday 09/11/20 The Intersection: Crypto and Wall Street This Week SAN Banco Santander $3.27 / -0.02 (-0.61%) 12/21/20 Unusually active option classes on open December 21st 09/22/20 Largest borrow rate increases among liquid names 09/21/20 Largest borrow rate increases among liquid names 09/18/20 Largest borrow rate increases among liquid names
Recommendations	BBVA price target raised to EUR 4.30 from EUR 4 at Barclays » 15:08 01/19/21 01/19 15:08 01/19/21 15:08 BBVA BBVA $4.92 / -0.025 (-0.51%) Barclays analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BBVA BBVA $4.92 / -0.025 (-0.51%) 11/27/20 Sabadell says board unanimously agreed to end talks with BBVA 11/27/20 BBVA says Sabadell merger talks have ended with no agreement 11/16/20 Banco Sabadell confirms merger talks with BBVA, says no decision made 11/16/20 BBVA confirms talks with Banco Sabadell regarding potential merger BBVA BBVA $4.92 / -0.025 (-0.51%) 01/15/21 Morgan Stanley BBVA price target raised to EUR 4.70 from EUR 4 at Morgan Stanley 01/11/21 Deutsche Bank BBVA price target raised to EUR 4.75 from EUR 4.40 at Deutsche Bank 12/04/20 Keefe Bruyette BBVA upgraded to Market Perform from Underperform at Keefe Bruyette 11/30/20 Stephens PNC Financial downgraded to Equal Weight from Overweight at Stephens BBVA BBVA $4.92 / -0.025 (-0.51%) 11/16/20 PNC Financial expects acquisition of BBVA subsidiary to be 21% accretive in 2022 BBVA BBVA $4.92 / -0.025 (-0.51%) 11/16/20 BBVA hires JPMorgan to study Sabadell merger options, El Confidencial reports 11/15/20 PNC in advanced talks to buy U.S. arm of BBVA, WSJ reports BBVA BBVA $4.92 / -0.025 (-0.51%) 11/16/20 Fly Intel: Wall Street's top stories for Monday 11/16/20 Fly Intel: Wall Street's top stories at midday
Recommendations	ASML price target raised to EUR 525 from EUR 475 at Barclays » 15:06 01/19/21 01/19 15:06 01/19/21 15:06 ASML ASML $547.30 / +19.37 (+3.67%) Barclays analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Periodicals Events ASML ASML $547.30 / +19.37 (+3.67%) 01/15/21 JPMorgan ASML price target raised to EUR 437 from EUR 408 at JPMorgan 01/14/21 Barclays ASML price target raised to EUR 475 from EUR 425 at Barclays 01/13/21 UBS ASML price target raised to EUR 430 from EUR 395 at UBS 01/12/21 Deutsche Bank ASML price target raised to EUR 375 from EUR 325 at Deutsche Bank ASML ASML $547.30 / +19.37 (+3.67%) 10/14/20 ASML sees Q4 revenue EUR3.6B-EUR3.8B 10/14/20 ASML reports Q3 EPS EUR2.54 vs. EUR1.79 last quarter ASML ASML $547.30 / +19.37 (+3.67%) 11/13/20 TSMC places EUV equipment orders with ASML for 2021, DigiTimes reports 02/11/21 Technology & Internet Virtual Conference 01/26/21 ASML 01/27/21 ASML
Recommendations	Alimentation Couche-Tard price target raised to C$42 from C$37 at Barclays » 15:04 01/19/21 01/19 15:04 01/19/21 15:04 ANCUF Alimentation Couche-Tard $0.00 / + (+0.00%) Barclays analyst Karen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ANCUF Alimentation Couche-Tard $0.00 / + (+0.00%) 01/13/21 Alimentation Couche-Tard confirms offer for Carrefour at EUR20 per share 01/12/21 Carrefour approached by Couche-Tard with combination project ANCUF Alimentation Couche-Tard $0.00 / + (+0.00%) 11:08 Today National Bank Alimentation Couche-Tard price target lowered to C$49 at National Bank 11:07 Today TD Securities Alimentation Couche-Tard price target lowered to C$45 at TD Securities 01/18/21 BMO Capital Alimentation downgraded to Market Perform from Outperform at BMO Capital 01/15/21 CIBC Alimentation Couche-Tard price target lowered to C$46 from C$52 at CIBC ANCUF Alimentation Couche-Tard $0.00 / + (+0.00%) 01/15/21 Alimentation Couche-Tard, Carrefour abandon merger talks, Reuters says 01/15/21 Alimentation Couche-Tard, Carrefour to end merger talks, Bloomberg reports 01/13/21 France not in favor of sale of Carrefour to Couche-Tard, Bloomberg reports
Options	Zions Bancorp options imply 4.3% move in share price post-earnings » 15:04 01/19/21 01/19 15:04 01/19/21 15:04 ZION Zions Bancorp $48.98 / -0.18 (-0.37%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events ZION Zions Bancorp $48.98 / -0.18 (-0.37%) 01/07/21 B. Riley Securities Zions Bancorp price target raised to $55 from $52 at B. Riley Securities 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight with $50 target at Barclays 01/04/21 Barclays Zions Bancorp downgraded to Equal Weight from Overweight at Barclays 12/07/20 Evercore ISI Zions Bancorp upgraded to Outperform from In Line at Evercore ISI ZION Zions Bancorp $48.98 / -0.18 (-0.37%) 13:40 Today Notable companies reporting after market close 10/19/20 Zions Bancorp reports Q3 EPS $1.01, consensus 88c 07/20/20 Zions Bancorp reports Q2 EPS 34c, consensus 38c 07/20/20 Notable companies reporting after market close ZION Zions Bancorp $48.98 / -0.18 (-0.37%) 10/19/20 Fly Intel: After-Hours Movers 17:30 Today Zions Bancorp - ZION

Events

Earnings calls, analyst events, roadshows and more

Today at 16:00

Treasury Int'l Capital: Net L-T Securities Transactions: November 2020 Government Event
IBKR
Today at 16:30

Interactive Brokers - IBKR Conference Calls
UTHR
Today at 16:30

United Therapeutics - UTHR Conference Calls
AVO
Today at 17:00

Mission Produce - AVO Conference Calls
JBHT
Today at 17:00

J.B. Hunt - JBHT Conference Calls
ZION
Today at 17:30

Zions Bancorp - ZION Conference Calls
NFLX
Today at 18:00

Netflix - NFLX Conference Calls
MRK ...
Tomorrow at 00:00

PDUFA Date for Vericiguat Government Event
Tomorrow at 00:00

16th Annual Scotiabank Canadian Multi-Family REIT Panel Conferences

Virtual Conference
MIND ...
Tomorrow at 00:00

17th Annual Small & Microcap Virtual Investor Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital $32.80 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $16.00-18.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

U.S. personal income/consumption preview

TODAY'S FREE FLY STORIES

Get Full Fly Access